Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19

Project: Research project

Project Details


We recently completed a detailed assessment of lung fluid samples from 86 patients with COVID-19 and 254 patients with pneumonia from other causes. This analysis suggested specific mechanisms by which SARS-CoV-2 causes severe disease in some patients and identified possible strategies to target these mechanisms, which we test in this application.
Effective start/end date4/1/223/31/26


  • National Heart, Lung, and Blood Institute (5R01HL158139-02)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.